AR011806A1 - Formulacion farmaceutica para administracion oral de un principio activo, (compuesto de amonio cuaternario ciclico) y procedimiento para prepararla - Google Patents
Formulacion farmaceutica para administracion oral de un principio activo, (compuesto de amonio cuaternario ciclico) y procedimiento para prepararlaInfo
- Publication number
- AR011806A1 AR011806A1 ARP980100676A ARP980100676A AR011806A1 AR 011806 A1 AR011806 A1 AR 011806A1 AR P980100676 A ARP980100676 A AR P980100676A AR P980100676 A ARP980100676 A AR P980100676A AR 011806 A1 AR011806 A1 AR 011806A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- formula
- alkyl
- oral administration
- alkoxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Abstract
Composicion farmacéutica para administracion oral de un principio activo de formula (I), en la cual: A(-) es un anion farmacéuticamente aceptable;Am(+) representa i) o bien un grupo Am1(+) de formula (II) en la cual: Ar1 representa un fenilono substituido o substituido una o varias veces, por unsubstituyente elegido entre un átomo de halogeno, un hidroxi, un (C1-C4)alcoxi, un (C1-C4)alquilo o un trifluorometilo, siendo dichos substituyentes idénticoso diferentes; x es cero o uno; W1 representa un (C1-C6)alquilo o un grupo bencilo; el substituyente W1 se encuentra en posicion axial o bien en posicionecuatorial; ii) o bien un grupo Am2(+) de formula (III), en la cual: Ar1, x y W1 son tal como se los ha definido anteriormente;R1 representa un hidroxi, un(C1-C4)alcoxi, un formiloxi, un (C1-C3)alquilcarboniloxi, un carboxi, un (C1-C4)alcoxicarbonilo, un ciano, un (C1-C3)alquilcarbonilamino, un mercapto,un (C1-C4)alquiltio; iii) o bien un grupo Am3(+) de formula (IV)en la cual: Ar1 y W1 son tal como se los ha definido anteriormente; R2 representa elhidrogeno, un (C1-C3)alquilo, un (C1-C3)alquilcarbonilo; iv) o bien un grupo Am4(+) de formula (V) en el cual: Ar1 y x son tal como se los ha definidoanteriormente; p es uno o dos; v) o bien un grupo Am5(+) de formula (VI) en la cual: Ar1 y x son tal como se los ha definido anteriormente; Ar representa unfenilo no substituido o substituido una o dos veces por un substituyente elegido entre un átomode halogeno, (C1-C3)alcoxi, un (C1-C3)alquilo o untrifluorometilo, siendo dichos substituyentes idénticos o diferentes, un naftilo, un indolilo; Q e Y representan uno de los grupos de valoressiguientes: a)Q1 e Y1; Q2 y Y2 cuando Am(+) representa un grupo Am1(+), Am2(+), Am4(+) o Am5(+); c)Q3 e Y3 cuando Am(+) representa un grupo Am1(+), Am2(+), o
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9701826A FR2759585B1 (fr) | 1997-02-17 | 1997-02-17 | Formulations pharmaceutiques presentees sous forme seche pour l'administration orale d'un compose ammonium quaternaire cyclique |
Publications (1)
Publication Number | Publication Date |
---|---|
AR011806A1 true AR011806A1 (es) | 2000-09-13 |
Family
ID=9503805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980100676A AR011806A1 (es) | 1997-02-17 | 1998-02-16 | Formulacion farmaceutica para administracion oral de un principio activo, (compuesto de amonio cuaternario ciclico) y procedimiento para prepararla |
Country Status (19)
Country | Link |
---|---|
US (1) | US6303626B1 (es) |
EP (1) | EP0981340B1 (es) |
JP (1) | JP2001511796A (es) |
AR (1) | AR011806A1 (es) |
AT (1) | ATE210436T1 (es) |
AU (1) | AU6405098A (es) |
BR (1) | BR9807406A (es) |
CA (1) | CA2281607A1 (es) |
CO (1) | CO4920216A1 (es) |
DE (1) | DE69802921T2 (es) |
DK (1) | DK0981340T3 (es) |
ES (1) | ES2172116T3 (es) |
FR (1) | FR2759585B1 (es) |
HK (1) | HK1023509A1 (es) |
HR (1) | HRP980074A2 (es) |
NO (1) | NO993927D0 (es) |
PT (1) | PT981340E (es) |
WO (1) | WO1998035663A1 (es) |
ZA (1) | ZA981288B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040151769A1 (en) * | 2002-12-31 | 2004-08-05 | Boehringer Ingelheim International Gmbh | Film coated tablet containing an extract of red vine leaves |
US20060210625A1 (en) * | 2003-11-04 | 2006-09-21 | Shire Laboratories, Inc. | Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms |
DE10355461A1 (de) * | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
CN102188424B (zh) * | 2011-03-23 | 2013-03-27 | 浙江理工大学 | Sr140333的抗血癌作用 |
US9334319B2 (en) | 2012-04-20 | 2016-05-10 | Abbvie Inc. | Low acidic species compositions |
WO2013158273A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Methods to modulate c-terminal lysine variant distribution |
WO2014151901A1 (en) * | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Improvement of mammalian cell culture performance through surfactant supplementation of feed media |
US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
WO2015073884A2 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2676054B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2688219B1 (fr) | 1992-03-03 | 1994-07-08 | Sanofi Elf | Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant. |
FR2696178B1 (fr) * | 1992-09-30 | 1994-12-30 | Sanofi Elf | Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
US5679693A (en) | 1992-09-30 | 1997-10-21 | Sanofi | 1-azoniabicyclo 2.2.1!heptanes, method of preparing them and pharmaceutical compositions in which they are present |
FR2717804B1 (fr) | 1994-03-25 | 1996-06-21 | Sanofi Sa | Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
FR2717802B1 (fr) * | 1994-03-25 | 1996-06-21 | Sanofi Sa | Nouveaux composés aromatiques, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
MX9701305A (es) * | 1994-08-25 | 1998-05-31 | Merrell Pharma Inc | Piperidinas sustituidas novedosas utiles para el tratamiento de enfermedades alergicas. |
FR2725986B1 (fr) | 1994-10-21 | 1996-11-29 | Adir | Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2725900B1 (fr) * | 1994-10-21 | 1997-07-18 | Sanofi Sa | Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice |
FR2729954B1 (fr) | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
FR2729951B1 (fr) * | 1995-01-30 | 1997-04-18 | Sanofi Sa | Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant |
-
1997
- 1997-02-17 FR FR9701826A patent/FR2759585B1/fr not_active Expired - Fee Related
-
1998
- 1998-02-13 HR HR9701826A patent/HRP980074A2/hr not_active Application Discontinuation
- 1998-02-16 AR ARP980100676A patent/AR011806A1/es unknown
- 1998-02-17 ES ES98909550T patent/ES2172116T3/es not_active Expired - Lifetime
- 1998-02-17 DE DE69802921T patent/DE69802921T2/de not_active Expired - Fee Related
- 1998-02-17 WO PCT/FR1998/000299 patent/WO1998035663A1/fr active IP Right Grant
- 1998-02-17 ZA ZA981288A patent/ZA981288B/xx unknown
- 1998-02-17 AT AT98909550T patent/ATE210436T1/de not_active IP Right Cessation
- 1998-02-17 CO CO98008406A patent/CO4920216A1/es unknown
- 1998-02-17 DK DK98909550T patent/DK0981340T3/da active
- 1998-02-17 AU AU64050/98A patent/AU6405098A/en not_active Abandoned
- 1998-02-17 JP JP53543398A patent/JP2001511796A/ja active Pending
- 1998-02-17 EP EP98909550A patent/EP0981340B1/fr not_active Expired - Lifetime
- 1998-02-17 BR BR9807406-7A patent/BR9807406A/pt not_active IP Right Cessation
- 1998-02-17 CA CA002281607A patent/CA2281607A1/en not_active Abandoned
- 1998-02-17 PT PT98909550T patent/PT981340E/pt unknown
- 1998-02-17 US US09/355,560 patent/US6303626B1/en not_active Expired - Fee Related
-
1999
- 1999-08-16 NO NO993927A patent/NO993927D0/no not_active Application Discontinuation
-
2000
- 2000-05-03 HK HK00102675A patent/HK1023509A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FR2759585A1 (fr) | 1998-08-21 |
HRP980074A2 (en) | 1998-10-31 |
ES2172116T3 (es) | 2002-09-16 |
NO993927L (no) | 1999-08-16 |
DE69802921T2 (de) | 2002-08-29 |
US6303626B1 (en) | 2001-10-16 |
CO4920216A1 (es) | 2000-05-29 |
CA2281607A1 (en) | 1998-08-20 |
PT981340E (pt) | 2002-05-31 |
EP0981340B1 (fr) | 2001-12-12 |
WO1998035663A1 (fr) | 1998-08-20 |
HK1023509A1 (en) | 2000-09-15 |
ZA981288B (en) | 1998-08-26 |
AU6405098A (en) | 1998-09-08 |
EP0981340A1 (fr) | 2000-03-01 |
DE69802921D1 (de) | 2002-01-24 |
ATE210436T1 (de) | 2001-12-15 |
JP2001511796A (ja) | 2001-08-14 |
NO993927D0 (no) | 1999-08-16 |
DK0981340T3 (da) | 2002-03-25 |
BR9807406A (pt) | 2000-03-14 |
FR2759585B1 (fr) | 1999-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2328820T3 (es) | Derivados de 4-(pirazol-3-ilamino)pirimidina para uso en el tratamiento de cancer. | |
AR056511A1 (es) | Derivados de 2-aminopirimidinas, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por el receptor de histamina h4 | |
AR011806A1 (es) | Formulacion farmaceutica para administracion oral de un principio activo, (compuesto de amonio cuaternario ciclico) y procedimiento para prepararla | |
HUP0300565A2 (hu) | PDE 5 inhibitor hatású 8-kinolin-xantin- és 8-izo-kinolin-xantin-származékok, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
DK1268471T3 (da) | N-heterocykliske derivater som NOS-inhibitorer | |
AR073687A1 (es) | Agonistas de receptores cb2, derivados de oxazoles y/o triazoles, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento del dolor, enfermedades autoinmunes y alergicas, entre otras. | |
EA201791254A1 (ru) | Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета | |
AR044011A1 (es) | Antagonistas de mchr1 heterociclicos | |
AR043049A1 (es) | Derivados de hidantoina, proceso de preparacion del mismo y composicion farmaceutica | |
WO2004014388A8 (en) | 6,6-fused heteroaryl derivatives as matrix metalloproteinase inhibitors | |
AU2003250471A8 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
AR041864A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
SE0301701D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
AR061185A1 (es) | Compuestos heterociclicos como inhibidores de hsp90. composiciones farmaceuticas. | |
NO20063619L (no) | Diarylmetylpiperazinderivater, fremstilling og anvendelse derav | |
IL173809A0 (en) | Imidazopyridine derivatives and pharmaceutical compositions containing the same | |
AR029758A1 (es) | Un derivado del grupo a de las estreptograminas, su preparacion y las composiciones farmaceuticas que los contienen | |
SE0301699D0 (sv) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
NO20072078L (no) | Indolderivater som inhibitorer av loselig adenylsyklase | |
WO2004062562A3 (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
PE20040658A1 (es) | Derivados de 3-guanidinocarbonil-1-heteroaril-pirrol, procedimiento de preparacion e intermediarios de este procedimiento y composiciones farmaceuticas que los comprenden | |
HUP0303457A2 (hu) | Antimikrobiális hatású 2-piridonok, ezeket tartalmazó készítmények és alkalmazásuk | |
AR035020A1 (es) | Enaminonas heterociclicas aril sustituidas, procedimiento para su obtencion, procedimiento para la lucha contra el crecimiento indeseable de las plantas y/o contra las pestes animales, empleo de dichos compuestos para la lucha contra las plantas indeseables y/o contra las pestes animales, y composic | |
AR074629A1 (es) | Derivados de 1-bencil-cinolin-4-(1h)-ona sustituidos, su preparacion, composiciones farmaceuticas y su uso en el tratamiento de patologias asociadas con receptores de los cannabinoides cb2 | |
AR013004A1 (es) | Derivados de aminospiropiperidina quinazolina, composicion farmaceutica, uso de dichos derivados en la preparacion de medicamentos, proceso para lapreparacion de dichos derivados y compuestos intermediarios para su exclusivo uso en dicho proceso. |